BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li J, Qin X, Wu R, Wan L, Zhang L, Liu R. Circular RNA circFBXO11 modulates hepatocellular carcinoma progress and oxaliplatin resistance through miR-605/FOXO3/ABCB1 axis. J Cell Mol Med 2020;24:5152-61. [PMID: 32222024 DOI: 10.1111/jcmm.15162] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Xi SJ, Cai WQ, Wang QQ, Peng XC. Role of circular RNAs in gastrointestinal tumors and drug resistance. World J Clin Cases 2021; 9(34): 10400-10417 [PMID: 35004973 DOI: 10.12998/wjcc.v9.i34.10400] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Hussen BM, Honarmand Tamizkar K, Hidayat HJ, Taheri M, Ghafouri-Fard S. The role of circular RNAs in the development of hepatocellular carcinoma. Pathol Res Pract 2021;223:153495. [PMID: 34051512 DOI: 10.1016/j.prp.2021.153495] [Reference Citation Analysis]
3 Cui Y, Zhao X, Wu Y. Circ_0005918 Sponges miR-622 to Aggravate Intervertebral Disc Degeneration. Front Cell Dev Biol 2022;10:905213. [DOI: 10.3389/fcell.2022.905213] [Reference Citation Analysis]
4 Li J, Qin X, Wu R, Wan L, Zhang L, Liu R. Circular RNA circFBXO11 modulates hepatocellular carcinoma progress and oxaliplatin resistance through miR-605/FOXO3/ABCB1 axis. J Cell Mol Med 2020;24:5152-61. [PMID: 32222024 DOI: 10.1111/jcmm.15162] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
5 Wang S, Liu D, Wei H, Hua Y, Shi G, Qiao J. The hsa_circRNA_102049 mediates the sorafenib sensitivity of hepatocellular carcinoma cells by regulating Reelin gene expression. Bioengineered 2022;13:2272-84. [PMID: 35034536 DOI: 10.1080/21655979.2021.2024332] [Reference Citation Analysis]
6 Wang L, Li B, Yi X, Xiao X, Zheng Q, Ma L. Circ_0036412 affects the proliferation and cell cycle of hepatocellular carcinoma via hedgehog signaling pathway. J Transl Med 2022;20:154. [PMID: 35382824 DOI: 10.1186/s12967-022-03305-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Zhang Y, Wang Y. Circular RNAs in Hepatocellular Carcinoma: Emerging Functions to Clinical Significances. Front Oncol 2021;11:667428. [PMID: 34055634 DOI: 10.3389/fonc.2021.667428] [Reference Citation Analysis]
8 Louis C, Leclerc D, Coulouarn C. Emerging roles of circular RNAs in liver cancer. JHEP Rep 2022;4:100413. [PMID: 35036887 DOI: 10.1016/j.jhepr.2021.100413] [Reference Citation Analysis]
9 Xu XF, Yang XK, Song Y, Chen BJ, Yu X, Xu T, Chen ZL. Dysregulation of Non-coding RNAs mediates Cisplatin Resistance in Hepatocellular Carcinoma and therapeutic strategies. Pharmacol Res 2021;:105906. [PMID: 34543740 DOI: 10.1016/j.phrs.2021.105906] [Reference Citation Analysis]
10 Lin JC, Zhu NX, Wu LF. Research progress of circRNAs in chemotherapy resistance of digestive system neoplasms. Shijie Huaren Xiaohua Zazhi 2021; 29(21): 1237-1247 [DOI: 10.11569/wcjd.v29.i21.1237] [Reference Citation Analysis]
11 Fan W, Chen L, Wu X, Zhang T. Circ_0031242 Silencing Mitigates the Progression and Drug Resistance in DDP-Resistant Hepatoma Cells by the miR-924/POU3F2 Axis. Cancer Manag Res 2021;13:743-55. [PMID: 33531841 DOI: 10.2147/CMAR.S272851] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Aishanjiang K, Wei XD, Fu Y, Lin X, Ma Y, Le J, Han Q, Wang X, Kong X, Gu J, Wu H. Circular RNAs and Hepatocellular Carcinoma: New Epigenetic Players With Diagnostic and Prognostic Roles. Front Oncol 2021;11:653717. [PMID: 33959506 DOI: 10.3389/fonc.2021.653717] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Liu X, Gao L, Shi S, Yang Y. Clinical Significance of has_circ_0055625 in Colon Cancer Patients Undergoing FOLFOX Chemotherapy Treatment. Int J Gen Med 2021;14:221-7. [PMID: 33519228 DOI: 10.2147/IJGM.S290440] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Fang N, Ding GW, Ding H, Li J, Liu C, Lv L, Shi YJ. Research Progress of Circular RNA in Gastrointestinal Tumors. Front Oncol 2021;11:665246. [PMID: 33937077 DOI: 10.3389/fonc.2021.665246] [Reference Citation Analysis]
15 Liu Y, Wang Y, Li X, Jia Y, Wang J, Ao X. FOXO3a in cancer drug resistance. Cancer Letters 2022. [DOI: 10.1016/j.canlet.2022.215724] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Yang S, Pang L, Dai W, Wu S, Ren T, Duan Y, Zheng Y, Bi S, Zhang X, Kong J. Role of Forkhead Box O Proteins in Hepatocellular Carcinoma Biology and Progression (Review). Front Oncol 2021;11:667730. [PMID: 34123834 DOI: 10.3389/fonc.2021.667730] [Reference Citation Analysis]
17 Zhao X, Wang Y, Yu Q, Yu P, Zheng Q, Yang X, Gao D. Circular RNAs in gastrointestinal cancer: Current knowledge, biomarkers and targeted therapy (Review). Int J Mol Med 2020;46:1611-32. [PMID: 33000182 DOI: 10.3892/ijmm.2020.4731] [Reference Citation Analysis]
18 Ashrafizadeh M, Zarrabi A, Hushmandi K, Zarrin V, Moghadam ER, Hashemi F, Makvandi P, Samarghandian S, Khan H, Hashemi F, Najafi M, Mirzaei H. Toward Regulatory Effects of Curcumin on Transforming Growth Factor-Beta Across Different Diseases: A Review. Front Pharmacol 2020;11:585413. [PMID: 33381035 DOI: 10.3389/fphar.2020.585413] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
19 Singh D, Kesharwani P, Alhakamy NA, Siddique HR. Accentuating CircRNA-miRNA-Transcription Factors Axis: A Conundrum in Cancer Research. Front Pharmacol 2021;12:784801. [PMID: 35087404 DOI: 10.3389/fphar.2021.784801] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
20 Zhong Y, Wang D, Ding Y, Tian G, Jiang B. Circular RNA circ_0032821 contributes to oxaliplatin (OXA) resistance of gastric cancer cells by regulating SOX9 via miR-515-5p. Biotechnol Lett 2021;43:339-51. [PMID: 33123829 DOI: 10.1007/s10529-020-03036-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
21 Wang S, Qian L, Cao T, Xu L, Jin Y, Hu H, Fu Q, Li Q, Wang Y, Wang J, Xia Y, Huang X. Advances in the Study of CircRNAs in Tumor Drug Resistance. Front Oncol 2022;12:868363. [DOI: 10.3389/fonc.2022.868363] [Reference Citation Analysis]
22 Fondevila F, Méndez-Blanco C, Fernández-Palanca P, Payo-Serafín T, van Pelt J, Verslype C, González-Gallego J, Mauriz JL. Autophagy-Related Chemoprotection against Sorafenib in Human Hepatocarcinoma: Role of FOXO3 Upregulation and Modulation by Regorafenib. Int J Mol Sci 2021;22:11770. [PMID: 34769197 DOI: 10.3390/ijms222111770] [Reference Citation Analysis]
23 Dashti F, Mirazimi SMA, Rabiei N, Fathazam R, Rabiei N, Piroozmand H, Vosough M, Rahimian N, Hamblin MR, Mirzaei H. The role of non-coding RNAs in chemotherapy for gastrointestinal cancers. Mol Ther Nucleic Acids 2021;26:892-926. [PMID: 34760336 DOI: 10.1016/j.omtn.2021.10.004] [Reference Citation Analysis]
24 Tang Y, Jiang M, Jiang HM, Ye ZJ, Huang YS, Li XS, Qin BY, Zhou RS, Pan HF, Zheng DY. The Roles of circRNAs in Liver Cancer Immunity. Front Oncol 2020;10:598464. [PMID: 33614486 DOI: 10.3389/fonc.2020.598464] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
25 Sobel Naveh NS, Traxler EM, Duffy KA, Kalish JM. Molecular networks of hepatoblastoma predisposition and oncogenesis in Beckwith-Wiedemann syndrome. Hepatol Commun 2022. [PMID: 35507738 DOI: 10.1002/hep4.1972] [Reference Citation Analysis]
26 Zhang Y, Wang D, Zhu T, Yu J, Wu X, Lin W, Zhu M, Dai Y, Zhu J. CircPUM1 promotes hepatocellular carcinoma progression through the miR-1208/MAP3K2 axis. J Cell Mol Med 2021;25:600-12. [PMID: 33320435 DOI: 10.1111/jcmm.15998] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
27 Tao X, Shao Y, Yan J, Yang L, Ye Q, Wang Q, Lu R, Guo J. Biological roles and potential clinical values of circular RNAs in gastrointestinal malignancies. Cancer Biol Med 2021:j. [PMID: 33710802 DOI: 10.20892/j.issn.2095-3941.2020.0348] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Fondevila F, Fernández-Palanca P, Méndez-Blanco C, Payo-Serafín T, Lozano E, Marin JJG, González-Gallego J, Mauriz JL. Association of FOXO3 Expression with Tumor Pathogenesis, Prognosis and Clinicopathological Features in Hepatocellular Carcinoma: A Systematic Review with Meta-Analysis. Cancers (Basel) 2021;13:5349. [PMID: 34771514 DOI: 10.3390/cancers13215349] [Reference Citation Analysis]
29 Lv Q, Xia Q, Li A, Wang Z, Khawar MB. circRNA_101277 Influences Cisplatin Resistance of Colorectal Cancer Cells by Modulating the miR-370/IL-6 Axis. Genetics Research 2022;2022:1-7. [DOI: 10.1155/2022/4237327] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Shen H, Liu B, Xu J, Zhang B, Wang Y, Shi L, Cai X. Circular RNAs: characteristics, biogenesis, mechanisms and functions in liver cancer. J Hematol Oncol 2021;14:134. [PMID: 34461958 DOI: 10.1186/s13045-021-01145-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Ely A, Bloom K, Maepa MB, Arbuthnot P. Recent Update on the Role of Circular RNAs in Hepatocellular Carcinoma. J Hepatocell Carcinoma 2021;8:1-17. [PMID: 33542907 DOI: 10.2147/JHC.S268291] [Reference Citation Analysis]